Design of Vaccine Candidate Based on Ebola Virus Epitop With In Silico Approach

Erwin Prasetya Toepak, Sari Namarito Simarmata, Sudarman Rahman, Stevin Carolius Angga

Abstract


ABSTRACT

 

         The World Health Organization (WHO) recorded as many as 2,299 cases of death with a case percentage of 66% during 2018 to 2020 in the Democratic Republic of the Congo due to the Ebola virus. Ebola virus is a member of the Filoviridae family. One of the viro cores consists of glycoprotein (GP). Messenger RNA (mRNA) generates long GP chains for the attachment protein (GP 1) and the fusion protein (GP 2). Epitope-based vaccines are a promising approach because epitopes represent immunogenic regions that elicit immunity specifically. Epitope prediction was performed based on the GP EBOV sequence available in the Data Bank. The designed vaccine could be one of the candidates for the Ebola virus vaccine. The design of the virus with access to NCBI AAB81004 was carried out by testing such as B cell epitope, T cell, and their antigenicity using the VaxiJen v2.0 server and IEDB. The T cell epitope prediction results showed that 20 T cell epitopes interacted with the Major Histocompatibility Complex (MHC) with the highest score of 2.8069. B cell epitope by linear BepiPred assay had 77 candidate epitope peptides from sequence 401-477. Karplus and Schulz's flexibility predictions showed a predictive value of 1.119 with a threshold of 1.008, with the analyzed area having an antigenic tendency where the threshold area was yellow.

 

Keywords: Ebolavirus; Vaccine; Epitope B Cell; Epitope T Cell; In Silico


Full Text:

PDF

References


Dash, R., Das, R., Junaid, M., Akash, M. F. C., Islam, A., & Hosen, S. M. Z. (2017). In silico-based vaccine design against Ebola virus glycoprotein. Advances and Applications in Bioinformatics and Chemistry, 10(1), 11–28. https://doi.org/10.2147/AABC.S115859

Moghadam, S. R. J., Omidi, N., Bayrami, S., Moghadam, S. J., & SeyedAlinaghi, S. A. (2015). Ebola viral disease: A review literature. Asian Pacific Journal of Tropical Biomedicine, 5(4), 260–267. https://doi.org/10.1016/S2221-1691(15)30341-5

Patronov, A., & Doytchinova, I. (2013). T-cell epitope vaccine design by immunoinformatics. Open Biology, 3(JAN). https://doi.org/10.1098/rsob.120139

Rajak, H., Jain, D. K., Singh, A., Sharma, A. K., & Dixit, A. (2015). Ebola virus disease: Past, present and future. Asian Pacific Journal of Tropical Biomedicine, 5(5), 337–343. https://doi.org/10.1016/S2221-1691(15)30365-8

Sanchez-Trincado, J. L., Gomez-Perosanz, M., & Reche, P. A. (2017). Fundamentals and Methods for T- and B-Cell Epitope Prediction. Journal of Immunology Research. https://doi.org/10.1155/2017/2680160

Sanchez, A., Kiley, M. P., Holloway, B. P., McCormick, J. B., & Auperin, D. D. (1989). The nucleoprotein gene of ebola virus: Cloning, sequencing, and in vitro expression. Virology, 170(1), 81–91. https://doi.org/10.1016/0042-6822(89)90354-1

Sridhar, S. (2015). Clinical development of Ebola vaccines. Therapeutic Advances in Vaccines, 3(5–6), 125–138. https://doi.org/10.1177/2051013615611017

Zawilińska, B., & Kosz-Vnenchak, M. (2014). General introduction into the Ebola virus biology and disease. Folia Medica Cracoviensia, 54(3), 57–65.




DOI: http://dx.doi.org/10.20527/jstk.v16i1.12167

Article Metrics

Abstract view : 775 times
PDF - 514 times

Refbacks



Department of Chemistry
Faculty of Mathematics and Natural Sciences
Universitas Lambung Mangkurat
Jl. A. Yani KM. 36 Banjarbaru 70714, Indonesia
Email: [email protected]
ISSN: 1411-1616 E-ISSN: 2549-8215

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License .